<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38057315</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>11</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2059-3635</ISSN><JournalIssue CitedMedium="Internet"><Volume>8</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>06</Day></PubDate></JournalIssue><Title>Signal transduction and targeted therapy</Title><ISOAbbreviation>Signal Transduct Target Ther</ISOAbbreviation></Journal><ArticleTitle>Non-coding RNAs expression in SARS-CoV-2 infection: pathogenesis, clinical significance, and therapeutic targets.</ArticleTitle><Pagination><StartPage>441</StartPage><MedlinePgn>441</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">441</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41392-023-01669-0</ELocationID><Abstract><AbstractText>The coronavirus disease 2019 (COVID-19) pandemic has been looming globally for three years, yet the diagnostic and treatment methods for COVID-19 are still undergoing extensive exploration, which holds paramount importance in mitigating future epidemics. Host non-coding RNAs (ncRNAs) display aberrations in the context of COVID-19. Specifically, microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs) exhibit a close association with viral infection and disease progression. In this comprehensive review, an overview was presented of the expression profiles of host ncRNAs following SARS-CoV-2 invasion and of the potential functions in COVID-19 development, encompassing viral invasion, replication, immune response, and multiorgan deficits which include respiratory system, cardiac system, central nervous system, peripheral nervous system as well as long COVID. Furthermore, we provide an overview of several promising host ncRNA biomarkers for diverse clinical scenarios related to COVID-19, such as stratification biomarkers, prognostic biomarkers, and predictive biomarkers for treatment response. In addition, we also discuss the therapeutic potential of ncRNAs for COVID-19, presenting ncRNA-based strategies to facilitate the development of novel treatments. Through an in-depth analysis of the interplay between ncRNA and COVID-19 combined with our bioinformatic analysis, we hope to offer valuable insights into the stratification, prognosis, and treatment of COVID-19.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Xiaoxing</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), 100191, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Xiong</LastName><ForeName>Wandi</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Peking-Tsinghua Center for Life Sciences and PKU-IDG/McGovern Institute for Brain Research, Peking University, 100871, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Key Laboratory of Tropical Biological Resources of Ministry of Education, School of Pharmaceutical Sciences, Hainan University, 570228, Haikou, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ye</LastName><ForeName>Maosen</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences &amp; Yunnan Province, KIZ/CUHK Joint Laboratory of Bioresources and Molecular Research in Common Diseases, Kunming Institute of Zoology, Chinese Academy of Sciences, 650204, Kunming, Yunnan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Tangsheng</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Kai</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), 100191, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Suhua</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), 100191, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-8381-4071</Identifier><AffiliationInfo><Affiliation>National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yongxiang</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Institute of Brain Science and Brain-inspired Research, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, 250117, Jinan, Shandong, China. wang-yongxiang@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, China. wang-yongxiang@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Lin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), 100191, Beijing, China. linlu@bjmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Peking-Tsinghua Center for Life Sciences and PKU-IDG/McGovern Institute for Brain Research, Peking University, 100871, Beijing, China. linlu@bjmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, 100191, China. linlu@bjmu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bao</LastName><ForeName>Yanping</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing, 100191, China. baoyp@bjmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Brain Science and Brain-inspired Research, Shandong First Medical University &amp; Shandong Academy of Medical Sciences, 250117, Jinan, Shandong, China. baoyp@bjmu.edu.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Public Health, Peking University, 100191, Beijing, China. baoyp@bjmu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Signal Transduct Target Ther</MedlineTA><NlmUniqueID>101676423</NlmUniqueID><ISSNLinking>2059-3635</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D022661">RNA, Untranslated</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000092522" MajorTopicYN="N">Clinical Relevance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D022661" MajorTopicYN="N">RNA, Untranslated</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>11</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>7</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>6</Day><Hour>23</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38057315</ArticleId><ArticleId IdType="pmc">PMC10700414</ArticleId><ArticleId IdType="doi">10.1038/s41392-023-01669-0</ArticleId><ArticleId IdType="pii">10.1038/s41392-023-01669-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gong, Y. et al. COVID-19 induced economic slowdown and mental health issues. Front. Psychol.13, 777350 (2022). 10.3389/fpsyg.2022.777350</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2022.777350</ArticleId><ArticleId IdType="pmc">PMC8931846</ArticleId><ArticleId IdType="pubmed">35310204</ArticleId></ArticleIdList></Reference><Reference><Citation>World Economic Situation and Prospects 2023 (United Nations Department of Economic and Social Affairs, the United Nations Conference on Trade and Development, Economic Commission for Africa, Economic Commission for Europe, Economic Commission for Latin America and the Caribbean, Economic and Social Commission for Asia and the Pacific, Economic and Social Commission for Western Asia, and the United Nations World Tourism Organization, 2023).</Citation></Reference><Reference><Citation>DeGrace, M. M. et al. Defining the risk of SARS-CoV-2 variants on immune protection. Nature605, 640&#x2013;652 (2022). 10.1038/s41586-022-04690-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04690-5</ArticleId><ArticleId IdType="pmc">PMC9345323</ArticleId><ArticleId IdType="pubmed">35361968</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson, C. B., Farzan, M., Chen, B. &amp; Choe, H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell. Biol.23, 3&#x2013;20 (2022). 10.1038/s41580-021-00418-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-021-00418-x</ArticleId><ArticleId IdType="pmc">PMC8491763</ArticleId><ArticleId IdType="pubmed">34611326</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta, P. et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet395, 1033&#x2013;1034 (2020). 10.1016/S0140-6736(20)30628-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30628-0</ArticleId><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Wiersinga, W. J. et al. Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review. J. Am. Med. Assoc.324, 782&#x2013;793 (2020).10.1001/jama.2020.12839</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12839</ArticleId><ArticleId IdType="pubmed">32648899</ArticleId></ArticleIdList></Reference><Reference><Citation>Merad, M., Blish, C. A., Sallusto, F. &amp; Iwasaki, A. The immunology and immunopathology of COVID-19. Science375, 1122&#x2013;1127 (2022). 10.1126/science.abm8108</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm8108</ArticleId><ArticleId IdType="pubmed">35271343</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian, A. et al. Post-acute COVID-19 syndrome. Nat. Med.27, 601&#x2013;615 (2021). 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng, N. et al. A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action. Mol. Psychiatry28, 423&#x2013;433 (2022). 10.1038/s41380-022-01614-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01614-7</ArticleId><ArticleId IdType="pmc">PMC9168643</ArticleId><ArticleId IdType="pubmed">35668159</ArticleId></ArticleIdList></Reference><Reference><Citation>Slack, F. J. &amp; Chinnaiyan, A. M. The role of non-coding RNAs in oncology. Cell179, 1033&#x2013;1055 (2019). 10.1016/j.cell.2019.10.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.10.017</ArticleId><ArticleId IdType="pmc">PMC7347159</ArticleId><ArticleId IdType="pubmed">31730848</ArticleId></ArticleIdList></Reference><Reference><Citation>Beermann, J., Piccoli, M. T., Viereck, J. &amp; Thum, T. Non-coding RNAs in development and disease: Background, mechanisms, and therapeutic approaches. Physiol. Rev.96, 1297&#x2013;1325 (2016). 10.1152/physrev.00041.2015</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00041.2015</ArticleId><ArticleId IdType="pubmed">27535639</ArticleId></ArticleIdList></Reference><Reference><Citation>Statello, L., Guo, C. J., Chen, L. L. &amp; Huarte, M. Gene regulation by long non-coding RNAs and its biological functions. Nat. Rev. Mol. Cell. Biol.22, 96&#x2013;118 (2021). 10.1038/s41580-020-00315-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-00315-9</ArticleId><ArticleId IdType="pmc">PMC7754182</ArticleId><ArticleId IdType="pubmed">33353982</ArticleId></ArticleIdList></Reference><Reference><Citation>Memczak, S. et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature495, 333&#x2013;338 (2013). 10.1038/nature11928</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11928</ArticleId><ArticleId IdType="pubmed">23446348</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopp, F. &amp; Mendell, J. T. Functional classification and experimental dissection of long noncoding RNAs. Cell172, 393&#x2013;407 (2018). 10.1016/j.cell.2018.01.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.01.011</ArticleId><ArticleId IdType="pmc">PMC5978744</ArticleId><ArticleId IdType="pubmed">29373828</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, L. L. The expanding regulatory mechanisms and cellular functions of circular RNAs. Nat. Rev. Mol. Cell. Biol.21, 475&#x2013;490 (2020). 10.1038/s41580-020-0243-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41580-020-0243-y</ArticleId><ArticleId IdType="pubmed">32366901</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, Y., Li, Z., Chen, X. &amp; Zhang, S. Long non-coding RNAs: from disease code to drug role. Acta Pharm. Sin. B.11, 340&#x2013;354 (2021). 10.1016/j.apsb.2020.10.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2020.10.001</ArticleId><ArticleId IdType="pmc">PMC7893121</ArticleId><ArticleId IdType="pubmed">33643816</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, X. et al. Viral circular RNAs and their possible roles in virus-host interaction. Front. Immunol.13, 939768 (2022). 10.3389/fimmu.2022.939768</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.939768</ArticleId><ArticleId IdType="pmc">PMC9247149</ArticleId><ArticleId IdType="pubmed">35784275</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra, R., Kumar, A., Ingle, H. &amp; Kumar, H. The interplay between viral-derived miRNAs and host immunity during infection. Front. Immunol.10, 3079 (2019). 10.3389/fimmu.2019.03079</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.03079</ArticleId><ArticleId IdType="pmc">PMC6989438</ArticleId><ArticleId IdType="pubmed">32038626</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Z. et al. Viral long non-coding RNA regulates virus life-cycle and pathogenicity. Mol. Biol. Rep.49, 6693&#x2013;6700 (2022). 10.1007/s11033-022-07268-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11033-022-07268-6</ArticleId><ArticleId IdType="pmc">PMC8929458</ArticleId><ArticleId IdType="pubmed">35301646</ArticleId></ArticleIdList></Reference><Reference><Citation>Tycowski, K. T. et al. Viral noncoding RNAs: more surprises. Genes. Dev.29, 567&#x2013;584 (2015). 10.1101/gad.259077.115</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gad.259077.115</ArticleId><ArticleId IdType="pmc">PMC4378190</ArticleId><ArticleId IdType="pubmed">25792595</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai, Z. et al. Identification and characterization of circRNAs encoded by MERS-CoV, SARS-CoV-1 and SARS-CoV-2. Brief Bioinforma22, 1297&#x2013;1308 (2021).10.1093/bib/bbaa334</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbaa334</ArticleId><ArticleId IdType="pmc">PMC7799257</ArticleId><ArticleId IdType="pubmed">33757279</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydemir, M. N. et al. Computationally predicted SARS-COV-2 encoded microRNAs target NFKB, JAK/STAT and TGFB signaling pathways. Gene Rep.22, 101012 (2021). 10.1016/j.genrep.2020.101012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.genrep.2020.101012</ArticleId><ArticleId IdType="pmc">PMC7773562</ArticleId><ArticleId IdType="pubmed">33398248</ArticleId></ArticleIdList></Reference><Reference><Citation>Musazzi, L. et al. Stress, microRNAs, and stress-related psychiatric disorders: an overview. Mol. Psychiatry10.1038/s41380-023-02139-3 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37391530</ArticleId></ArticleIdList></Reference><Reference><Citation>Roggendorf, M. et al. Rational use of diagnostic tools in hepatitis C. J. Hepatol.24, 26&#x2013;34 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8836886</ArticleId></ArticleIdList></Reference><Reference><Citation>Foley, K. P., Leonard, M. W. &amp; Engel, J. D. Quantitation of RNA using the polymerase chain reaction. Trends Genet.9, 380&#x2013;385 (1993). 10.1016/0168-9525(93)90137-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-9525(93)90137-7</ArticleId><ArticleId IdType="pubmed">7508648</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogelstein, B. &amp; Kinzler, K. W. Digital PCR. Proc. Natl. Acad. Sci. USA96, 9236&#x2013;9241 (1999). 10.1073/pnas.96.16.9236</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.16.9236</ArticleId><ArticleId IdType="pmc">PMC17763</ArticleId><ArticleId IdType="pubmed">10430926</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojabad, A. A. et al. Droplet digital PCR of viral DNA/RNA, current progress, challenges, and future perspectives. J. Med. Virol.93, 4182&#x2013;4197 (2021). 10.1002/jmv.26846</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26846</ArticleId><ArticleId IdType="pmc">PMC8013307</ArticleId><ArticleId IdType="pubmed">33538349</ArticleId></ArticleIdList></Reference><Reference><Citation>Stark, R., Grzelak, M. &amp; Hadfield, J. RNA sequencing: the teenage years. Nat. Rev. Genet.20, 631&#x2013;656 (2019). 10.1038/s41576-019-0150-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-019-0150-2</ArticleId><ArticleId IdType="pubmed">31341269</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, Y. et al. Encoding method of single-cell spatial transcriptomics sequencing. Int. J. Biol. Sci.16, 2663&#x2013;2674 (2020). 10.7150/ijbs.43887</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.43887</ArticleId><ArticleId IdType="pmc">PMC7415427</ArticleId><ArticleId IdType="pubmed">32792863</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagheri-Hosseinabadi, Z. et al. The relationship between serum levels of interleukin-2 and IL-8 with circulating microRNA-10b in patients with COVID-19. Iran J. Immunol.18, 65&#x2013;73 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33787515</ArticleId></ArticleIdList></Reference><Reference><Citation>Parray, A. et al. SnoRNAs and miRNAs networks underlying COVID-19 disease severity. Vaccines9, 1056 (2021). 10.3390/vaccines9101056</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines9101056</ArticleId><ArticleId IdType="pmc">PMC8538251</ArticleId><ArticleId IdType="pubmed">34696164</ArticleId></ArticleIdList></Reference><Reference><Citation>Agwa, S. H. A. et al. In silico identification and clinical validation of a novel long non-coding RNA/mRNA/miRNA molecular network for potential biomarkers for discriminating SARS CoV-2 infection severity. Cells10, 3098 (2021). 10.3390/cells10113098</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10113098</ArticleId><ArticleId IdType="pmc">PMC8625524</ArticleId><ArticleId IdType="pubmed">34831321</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, X. et al. SARS-CoV-2 causes a significant stress response mediated by small RNAs in the blood of COVID-19 patients. Mol. Ther. Nucleic Acids27, 751&#x2013;762 (2022). 10.1016/j.omtn.2021.12.034</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2021.12.034</ArticleId><ArticleId IdType="pmc">PMC8719421</ArticleId><ArticleId IdType="pubmed">35003892</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, Y. et al. A study of differential circRNA and lncRNA expressions in COVID-19-infected peripheral blood. Sci. Rep.11, 7991 (2021). 10.1038/s41598-021-86134-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-86134-0</ArticleId><ArticleId IdType="pmc">PMC8041881</ArticleId><ArticleId IdType="pubmed">33846375</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, W. et al. Changes of small non-coding RNAs by severe acute respiratory syndrome coronavirus 2 infection. Front. Mol. Biosci.9, 821137 (2021).10.3389/fmolb.2022.821137</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2022.821137</ArticleId><ArticleId IdType="pmc">PMC8905365</ArticleId><ArticleId IdType="pubmed">35281271</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodrigues, A. C. et al. NEAT1 and MALAT1 are highly expressed in saliva and nasopharyngeal swab samples of COVID-19 patients. Mol. Oral. Microbiol.36, 291&#x2013;294 (2021). 10.1111/omi.12351</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/omi.12351</ArticleId><ArticleId IdType="pmc">PMC8661855</ArticleId><ArticleId IdType="pubmed">34463043</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald, J. T. et al. Role of miR-2392 in driving SARS-CoV-2 infection. Cell Rep.37, 109839 (2021). 10.1016/j.celrep.2021.109839</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109839</ArticleId><ArticleId IdType="pmc">PMC8481092</ArticleId><ArticleId IdType="pubmed">34624208</ArticleId></ArticleIdList></Reference><Reference><Citation>Mi, B. et al. SARS-CoV-2-induced overexpression of miR-4485 suppresses osteogenic differentiation and impairs fracture healing. Int. J. Biol. Sci.17, 1277&#x2013;1288 (2021). 10.7150/ijbs.56657</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.56657</ArticleId><ArticleId IdType="pmc">PMC8040480</ArticleId><ArticleId IdType="pubmed">33867845</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhold, D. et al. The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammation. J. Neuroinflammation20, 30 (2023). 10.1186/s12974-023-02711-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-023-02711-2</ArticleId><ArticleId IdType="pmc">PMC9909638</ArticleId><ArticleId IdType="pubmed">36759861</ArticleId></ArticleIdList></Reference><Reference><Citation>Centa, A. et al. Deregulated miRNA expression is associated with endothelial dysfunction in post-mortem lung biopsies of COVID-19 patients. Am. J. Physiol. Lung Cell. Mol. Physiol.320, L405&#x2013;L412 (2021). 10.1152/ajplung.00457.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00457.2020</ArticleId><ArticleId IdType="pmc">PMC7938642</ArticleId><ArticleId IdType="pubmed">33651636</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi-Kolli, M. et al. The expression patterns of MALAT-1, NEAT-1, THRIL, and miR-155-5p in the acute to the post-acute phase of COVID-19 disease. Braz. J. Infect. Dis.26, 102354 (2022). 10.1016/j.bjid.2022.102354</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bjid.2022.102354</ArticleId><ArticleId IdType="pmc">PMC9035361</ArticleId><ArticleId IdType="pubmed">35500644</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng, H. Y. et al. Longitudinal transcriptome analyses show robust T cell immunity during recovery from COVID-19. Signal Transduct. Target. Ther.5, 294 (2020). 10.1038/s41392-020-00457-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00457-4</ArticleId><ArticleId IdType="pmc">PMC7758413</ArticleId><ArticleId IdType="pubmed">33361761</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Pato, A. et al. Plasma miRNA profile at COVID-19 onset predicts severity status and mortality. Emerg. Microbes Infect.11, 676&#x2013;688 (2022). 10.1080/22221751.2022.2038021</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2022.2038021</ArticleId><ArticleId IdType="pmc">PMC8890551</ArticleId><ArticleId IdType="pubmed">35130828</ArticleId></ArticleIdList></Reference><Reference><Citation>Duecker, R. P. et al. The MiR-320 family is strongly downregulated in patients with COVID-19 induced severe respiratory failure. Int. J. Mol. Sci.22, 10351 (2021). 10.3390/ijms221910351</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221910351</ArticleId><ArticleId IdType="pmc">PMC8508658</ArticleId><ArticleId IdType="pubmed">34638691</ArticleId></ArticleIdList></Reference><Reference><Citation>Donyavi, T. et al. Acute and post-acute phase of COVID-19: analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC. Int. Immunopharmacol.97, 107641 (2021). 10.1016/j.intimp.2021.107641</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107641</ArticleId><ArticleId IdType="pmc">PMC8023203</ArticleId><ArticleId IdType="pubmed">33895478</ArticleId></ArticleIdList></Reference><Reference><Citation>Garg, A. et al. Circulating cardiovascular microRNAs in critically ill COVID-19 patients. Eur. J. Heart Fail23, 468&#x2013;475 (2021). 10.1002/ejhf.2096</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejhf.2096</ArticleId><ArticleId IdType="pmc">PMC8014268</ArticleId><ArticleId IdType="pubmed">33421274</ArticleId></ArticleIdList></Reference><Reference><Citation>Giuliani, A. et al. Circulating miR-320b and miR-483-5p levels are associated with COVID-19 in-hospital mortality. Mech. Ageing Dev.202, 111636 (2022). 10.1016/j.mad.2022.111636</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2022.111636</ArticleId><ArticleId IdType="pmc">PMC8809668</ArticleId><ArticleId IdType="pubmed">35122770</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson, J. C. et al. Integrated miRNA/cytokine/chemokine profiling reveals severity-associated step changes and principal correlates of fatality in COVID-19. iScience25, 103672 (2022). 10.1016/j.isci.2021.103672</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.103672</ArticleId><ArticleId IdType="pmc">PMC8686203</ArticleId><ArticleId IdType="pubmed">34957382</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutmann, C. et al. Association of cardiometabolic microRNAs with COVID-19 severity and mortality. Cardiovasc. Res118, 461&#x2013;474 (2022). 10.1093/cvr/cvab338</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvab338</ArticleId><ArticleId IdType="pmc">PMC8689968</ArticleId><ArticleId IdType="pubmed">34755842</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang, H. et al. The noncoding and coding transcriptional landscape of the peripheral immune response in patients with COVID-19. Clin. Transl. Med.10, e200 (2020). 10.1002/ctm2.200</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.200</ArticleId><ArticleId IdType="pmc">PMC7548099</ArticleId><ArticleId IdType="pubmed">33135345</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu, J. et al. Expression of plasma IFN signaling-related miRNAs during acute SARS-CoV-2 infection and its association with RBD-IgG antibody response. Virol. J.18, 244 (2021). 10.1186/s12985-021-01717-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-021-01717-7</ArticleId><ArticleId IdType="pmc">PMC8649682</ArticleId><ArticleId IdType="pubmed">34876159</ArticleId></ArticleIdList></Reference><Reference><Citation>Farr, R. J. et al. Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection. PLoS. Pathog.17, e1009759 (2021). 10.1371/journal.ppat.1009759</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009759</ArticleId><ArticleId IdType="pmc">PMC8318295</ArticleId><ArticleId IdType="pubmed">34320031</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, C. X. et al. Whole-transcriptome RNA sequencing reveals significant differentially expressed mRNAs, miRNAs, and lncRNAs and related regulating biological pathways in the peripheral blood of COVID-19 patients. Mediators Inflamm.2021, 6635925 (2021). 10.1155/2021/6635925</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/6635925</ArticleId><ArticleId IdType="pmc">PMC8018221</ArticleId><ArticleId IdType="pubmed">33833618</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng, J. et al. Risk stratification by long non-coding RNAs profiling in COVID-19 patients. J. Cell. Mol. Med.25, 4753&#x2013;4764 (2021). 10.1111/jcmm.16444</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.16444</ArticleId><ArticleId IdType="pmc">PMC8107096</ArticleId><ArticleId IdType="pubmed">33759345</ArticleId></ArticleIdList></Reference><Reference><Citation>Rombauts, A. et al. Dynamics of gene expression profiling and identification of high-risk patients for severe COVID-19. Biomedicines11, 1348 (2023). 10.3390/biomedicines11051348</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11051348</ArticleId><ArticleId IdType="pmc">PMC10216228</ArticleId><ArticleId IdType="pubmed">37239019</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe, B., Xie, Y. &amp; Al-Aly, Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat. Med.28, 2398&#x2013;2405 (2022). 10.1038/s41591-022-02051-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Aznaourova, M. et al. Single-cell RNA sequencing uncovers the nuclear decoy lincRNA PIRAT as a regulator of systemic monocyte immunity during COVID-19. Proc. Natl. Acad. Sci. USA119, e2120680119 (2022). 10.1073/pnas.2120680119</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2120680119</ArticleId><ArticleId IdType="pmc">PMC9457492</ArticleId><ArticleId IdType="pubmed">35998224</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, M. et al. Differential host circRNA expression profiles in human lung epithelial cells infected with SARS-CoV-2. Infect. Genet. Evol.93, 104923 (2021). 10.1016/j.meegid.2021.104923</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2021.104923</ArticleId><ArticleId IdType="pmc">PMC8123525</ArticleId><ArticleId IdType="pubmed">34004360</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang, R., Lee, S., Senavirathne, G. &amp; Lai, E. C. MicroRNAs in action: biogenesis, function and regulation. Nat. Rev. Genet. 10.1038/s41576-023-00611-y (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11087887</ArticleId><ArticleId IdType="pubmed">37380761</ArticleId></ArticleIdList></Reference><Reference><Citation>Kristensen, L. S. et al. The biogenesis, biology and characterization of circular RNAs. Nat. Rev. Genet.20, 675&#x2013;691 (2019). 10.1038/s41576-019-0158-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41576-019-0158-7</ArticleId><ArticleId IdType="pubmed">31395983</ArticleId></ArticleIdList></Reference><Reference><Citation>Skalsky, R. L. &amp; Cullen, B. R. Viruses, microRNAs, and host interactions. Annu. Rev. Microbiol.64, 123&#x2013;141 (2010). 10.1146/annurev.micro.112408.134243</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.micro.112408.134243</ArticleId><ArticleId IdType="pmc">PMC3621958</ArticleId><ArticleId IdType="pubmed">20477536</ArticleId></ArticleIdList></Reference><Reference><Citation>Libri, V., Miesen, P., van Rij, R. P. &amp; Buck, A. H. Regulation of microRNA biogenesis and turnover by animals and their viruses. Cell. Mol. Life. Sci.70, 3525&#x2013;3544 (2013). 10.1007/s00018-012-1257-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-012-1257-1</ArticleId><ArticleId IdType="pmc">PMC3771402</ArticleId><ArticleId IdType="pubmed">23354060</ArticleId></ArticleIdList></Reference><Reference><Citation>Arora, S. et al. Unravelling host-pathogen interactions: ceRNA network in SARS-CoV-2 infection (COVID-19). Gene762, 145057 (2020). 10.1016/j.gene.2020.145057</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gene.2020.145057</ArticleId><ArticleId IdType="pmc">PMC7428439</ArticleId><ArticleId IdType="pubmed">32805314</ArticleId></ArticleIdList></Reference><Reference><Citation>Garnier, N. et al. Genes involved in miRNA biogenesis are not downregulated in SARS-COV-2 infection. Viruses15, 1177 (2023). 10.3390/v15051177</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15051177</ArticleId><ArticleId IdType="pmc">PMC10222706</ArticleId><ArticleId IdType="pubmed">37243263</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann, M. et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell181, 271&#x2013;280 e278 (2020). 10.1016/j.cell.2020.02.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, Z. et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir. Med.8, 420&#x2013;422 (2020). 10.1016/S2213-2600(20)30076-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30076-X</ArticleId><ArticleId IdType="pmc">PMC7164771</ArticleId><ArticleId IdType="pubmed">32085846</ArticleId></ArticleIdList></Reference><Reference><Citation>Attaway, A. H. et al. Severe covid-19 pneumonia: pathogenesis and clinical management. BMJ372, n436 (2021). 10.1136/bmj.n436</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n436</ArticleId><ArticleId IdType="pubmed">33692022</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta, A. et al. Extrapulmonary manifestations of COVID-19. Nat. Med.26, 1017&#x2013;1032 (2020). 10.1038/s41591-020-0968-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Glowacka, I. et al. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J. Virol.85, 4122&#x2013;4134 (2011). 10.1128/JVI.02232-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02232-10</ArticleId><ArticleId IdType="pmc">PMC3126222</ArticleId><ArticleId IdType="pubmed">21325420</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuyama, S. et al. Efficient activation of the severe acute respiratory syndrome coronavirus spike protein by the transmembrane protease TMPRSS2. J. Virol.84, 12658&#x2013;12664 (2010). 10.1128/JVI.01542-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01542-10</ArticleId><ArticleId IdType="pmc">PMC3004351</ArticleId><ArticleId IdType="pubmed">20926566</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang, I. C. et al. SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J. Biol. Chem.281, 3198&#x2013;3203 (2006). 10.1074/jbc.M508381200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M508381200</ArticleId><ArticleId IdType="pmc">PMC8010168</ArticleId><ArticleId IdType="pubmed">16339146</ArticleId></ArticleIdList></Reference><Reference><Citation>Simmons, G. et al. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. USA102, 11876&#x2013;11881 (2005). 10.1073/pnas.0505577102</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0505577102</ArticleId><ArticleId IdType="pmc">PMC1188015</ArticleId><ArticleId IdType="pubmed">16081529</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas, G. Furin at the cutting edge: From protein traffic to embryogenesis and disease. Nat. Rev. Mol. Cell. Biol.3, 753&#x2013;766 (2002). 10.1038/nrm934</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm934</ArticleId><ArticleId IdType="pmc">PMC1964754</ArticleId><ArticleId IdType="pubmed">12360192</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann, M., Kleine-Weber, H. &amp; Pohlmann, S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol. Cell.78, 779&#x2013;784 (2020). 10.1016/j.molcel.2020.04.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2020.04.022</ArticleId><ArticleId IdType="pmc">PMC7194065</ArticleId><ArticleId IdType="pubmed">32362314</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, B. A. et al. Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature591, 293&#x2013;299 (2021). 10.1038/s41586-021-03237-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03237-4</ArticleId><ArticleId IdType="pmc">PMC8175039</ArticleId><ArticleId IdType="pubmed">33494095</ArticleId></ArticleIdList></Reference><Reference><Citation>Diallo, I. et al. Altered microRNA transcriptome in cultured human airway cells upon infection with SARS-CoV-2. Viruses15, 496 (2023). 10.3390/v15020496</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15020496</ArticleId><ArticleId IdType="pmc">PMC9962802</ArticleId><ArticleId IdType="pubmed">36851710</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta, P. K. et al. SARS-CoV-2 pandemic and research gaps: understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy. Theranostics10, 7448&#x2013;7464 (2020). 10.7150/thno.48076</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.48076</ArticleId><ArticleId IdType="pmc">PMC7330865</ArticleId><ArticleId IdType="pubmed">32642005</ArticleId></ArticleIdList></Reference><Reference><Citation>Sungnak, W. et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med.26, 681&#x2013;687 (2020). 10.1038/s41591-020-0868-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0868-6</ArticleId><ArticleId IdType="pmc">PMC8637938</ArticleId><ArticleId IdType="pubmed">32327758</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou, Y. J. et al. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell182, 429&#x2013;446 e414 (2020). 10.1016/j.cell.2020.05.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.042</ArticleId><ArticleId IdType="pmc">PMC7250779</ArticleId><ArticleId IdType="pubmed">32526206</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler, C. G. K. et al. SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell181, 1016&#x2013;1035 (2020). 10.1016/j.cell.2020.04.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.035</ArticleId><ArticleId IdType="pmc">PMC7252096</ArticleId><ArticleId IdType="pubmed">32413319</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan, A. T. et al. A computational and bioinformatic analysis of ACE2: an elucidation of its dual role in COVID-19 pathology and finding its associated partners as potential therapeutic targets. J. Biomol. Struct. Dyn.40, 1813&#x2013;1829 (2022). 10.1080/07391102.2020.1833760</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07391102.2020.1833760</ArticleId><ArticleId IdType="pmc">PMC7596956</ArticleId><ArticleId IdType="pubmed">33073716</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerard, L. et al. Increased angiotensin-converting enzyme 2 and loss of alveolar type ii cells in COVID-19-related acute respiratory distress syndrome. Am. J. Respir. Crit. Care Med.204, 1024&#x2013;1034 (2021). 10.1164/rccm.202012-4461OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.202012-4461OC</ArticleId><ArticleId IdType="pmc">PMC8663012</ArticleId><ArticleId IdType="pubmed">34449302</ArticleId></ArticleIdList></Reference><Reference><Citation>Nersisyan, S. et al. Potential role of cellular miRNAs in coronavirus-host interplay. PeerJ8, e9994 (2020). 10.7717/peerj.9994</Citation><ArticleIdList><ArticleId IdType="doi">10.7717/peerj.9994</ArticleId><ArticleId IdType="pmc">PMC7497610</ArticleId><ArticleId IdType="pubmed">32983652</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapira, T. et al. A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic. Nature605, 340&#x2013;348 (2022). 10.1038/s41586-022-04661-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04661-w</ArticleId><ArticleId IdType="pmc">PMC9095466</ArticleId><ArticleId IdType="pubmed">35344983</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, H. et al. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients. EBioMedicine70, 103500 (2021). 10.1016/j.ebiom.2021.103500</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103500</ArticleId><ArticleId IdType="pmc">PMC8302220</ArticleId><ArticleId IdType="pubmed">34311326</ArticleId></ArticleIdList></Reference><Reference><Citation>Matarese, A., Gambardella, J., Sardu, C. &amp; Santulli, G. miR-98 regulates TMPRSS2 expression in human endothelial cells: key implications for COVID-19. Biomedicines8, 462 (2020). 10.3390/biomedicines8110462</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines8110462</ArticleId><ArticleId IdType="pmc">PMC7693865</ArticleId><ArticleId IdType="pubmed">33143053</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang, Y. et al. Circulating microRNAs as emerging regulators of COVID-19. Theranostics13, 125&#x2013;147 (2023). 10.7150/thno.78164</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.78164</ArticleId><ArticleId IdType="pmc">PMC9800721</ArticleId><ArticleId IdType="pubmed">36593971</ArticleId></ArticleIdList></Reference><Reference><Citation>de Gonzalo-Calvo, D. et al. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients. Transl. Res.236, 147&#x2013;159 (2021). 10.1016/j.trsl.2021.05.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2021.05.004</ArticleId><ArticleId IdType="pmc">PMC8149473</ArticleId><ArticleId IdType="pubmed">34048985</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen, L. &amp; Zhong, L. Genomics functional analysis and drug screening of SARS-CoV-2. Genes Dis.7, 542&#x2013;550 (2020). 10.1016/j.gendis.2020.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gendis.2020.04.002</ArticleId><ArticleId IdType="pmc">PMC7195040</ArticleId><ArticleId IdType="pubmed">32363223</ArticleId></ArticleIdList></Reference><Reference><Citation>Cong, Y. et al. Nucleocapsid protein recruitment to replication-transcription complexes plays a crucial role in coronaviral life cycle. J. Virol.94, e01925&#x2013;19 (2020). 10.1128/JVI.01925-19</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01925-19</ArticleId><ArticleId IdType="pmc">PMC6997762</ArticleId><ArticleId IdType="pubmed">31776274</ArticleId></ArticleIdList></Reference><Reference><Citation>Arunachalam, P. S. et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science369, 1210&#x2013;1220 (2020). 10.1126/science.abc6261</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6261</ArticleId><ArticleId IdType="pmc">PMC7665312</ArticleId><ArticleId IdType="pubmed">32788292</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard, P. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science370, eabd4585 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell181, 1036&#x2013;1045 e1039 (2020). 10.1016/j.cell.2020.04.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>Oran, D. P. &amp; Topol, E. J. Prevalence of asymptomatic SARS-CoV-2 infection: a narrative review. Ann. Intern. Med.173, 362&#x2013;367 (2020). 10.7326/M20-3012</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-3012</ArticleId><ArticleId IdType="pmc">PMC7281624</ArticleId><ArticleId IdType="pubmed">32491919</ArticleId></ArticleIdList></Reference><Reference><Citation>Sette, A. &amp; Crotty, S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell184, 861&#x2013;880 (2021). 10.1016/j.cell.2021.01.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.01.007</ArticleId><ArticleId IdType="pmc">PMC7803150</ArticleId><ArticleId IdType="pubmed">33497610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramasamy, S. &amp; Subbian, S. Critical determinants of cytokine storm and type i interferon response in COVID-19 pathogenesis. Clin. Microbiol. Rev.34, e00299&#x2013;00220 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8142516</ArticleId><ArticleId IdType="pubmed">33980688</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin, P. Immune determinants of COVID-19 disease presentation and severity. Nat. Med.27, 28&#x2013;33 (2021). 10.1038/s41591-020-01202-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01202-8</ArticleId><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Lodish, H. F., Zhou, B., Liu, G. &amp; Chen, C. Z. Micromanagement of the immune system by microRNAs. Nat. Rev. Immunol.8, 120&#x2013;130 (2008). 10.1038/nri2252</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2252</ArticleId><ArticleId IdType="pubmed">18204468</ArticleId></ArticleIdList></Reference><Reference><Citation>Atianand, M. K., Caffrey, D. R. &amp; Fitzgerald, K. A. Immunobiology of long noncoding RNAs. Annu. Rev. Immunol.35, 177&#x2013;198 (2017). 10.1146/annurev-immunol-041015-055459</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-041015-055459</ArticleId><ArticleId IdType="pmc">PMC6449690</ArticleId><ArticleId IdType="pubmed">28125358</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan, L. &amp; Chen, Y. G. Circular RNAs in immune response and viral infection. Trends Biochem. Sci.45, 1022&#x2013;1034 (2020). 10.1016/j.tibs.2020.08.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2020.08.006</ArticleId><ArticleId IdType="pmc">PMC7642119</ArticleId><ArticleId IdType="pubmed">32900574</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, S. et al. The miRNA: a small but powerful RNA for COVID-19. Brief. Bioinforma22, 1137&#x2013;1149 (2021).10.1093/bib/bbab062</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbab062</ArticleId><ArticleId IdType="pmc">PMC7989616</ArticleId><ArticleId IdType="pubmed">33675361</ArticleId></ArticleIdList></Reference><Reference><Citation>Wood, E. R. et al. The role of phosphodiesterase 12 (PDE12) as a negative regulator of the innate immune response and the discovery of antiviral inhibitors. J. Biol. Chem.290, 19681&#x2013;19696 (2015). 10.1074/jbc.M115.653113</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.653113</ArticleId><ArticleId IdType="pmc">PMC4528132</ArticleId><ArticleId IdType="pubmed">26055709</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science369, 718&#x2013;724 (2020). 10.1126/science.abc6027</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6027</ArticleId><ArticleId IdType="pmc">PMC7402632</ArticleId><ArticleId IdType="pubmed">32661059</ArticleId></ArticleIdList></Reference><Reference><Citation>Moazzam-Jazi, M. et al. Interplay between SARS-CoV-2 and human long non-coding RNAs. J. Cell. Mol. Med.25, 5823&#x2013;5827 (2021). 10.1111/jcmm.16596</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.16596</ArticleId><ArticleId IdType="pmc">PMC8184717</ArticleId><ArticleId IdType="pubmed">33969601</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayaz, H. et al. Mapping CircRNA-miRNA-mRNA regulatory axis identifies hsa_circ_0080942 and hsa_circ_0080135 as a potential theranostic agents for SARS-CoV-2 infection. PLoS. ONE18, e0283589 (2023). 10.1371/journal.pone.0283589</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0283589</ArticleId><ArticleId IdType="pmc">PMC10101458</ArticleId><ArticleId IdType="pubmed">37053191</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu, L., Zhang, H., Dauphars, D. J. &amp; He, Y. W. A potential role of interleukin 10 in COVID-19 pathogenesis. Trends Immunol.42, 3&#x2013;5 (2021). 10.1016/j.it.2020.10.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2020.10.012</ArticleId><ArticleId IdType="pmc">PMC7605819</ArticleId><ArticleId IdType="pubmed">33214057</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra, A., Chanchal, S. &amp; Ashraf, M. Z. Host-viral interactions revealed among shared transcriptomics signatures of ARDS and thrombosis: a clue into COVID-19 pathogenesis. TH Open4, e403&#x2013;e412 (2020). 10.1055/s-0040-1721706</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0040-1721706</ArticleId><ArticleId IdType="pmc">PMC7746517</ArticleId><ArticleId IdType="pubmed">33354650</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai, A. H. et al. Dysregulated lysine acetyltransferase 2b promotes inflammatory bowel disease pathogenesis through transcriptional repression of interleukin-10. J. Crohns Colitis10, 726&#x2013;734 (2016). 10.1093/ecco-jcc/jjw020</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ecco-jcc/jjw020</ArticleId><ArticleId IdType="pubmed">26802082</ArticleId></ArticleIdList></Reference><Reference><Citation>Enguita, F. J. et al. The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response. Theranostics12, 3946&#x2013;3962 (2022). 10.7150/thno.73268</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.73268</ArticleId><ArticleId IdType="pmc">PMC9131284</ArticleId><ArticleId IdType="pubmed">35664076</ArticleId></ArticleIdList></Reference><Reference><Citation>Tayel, S. I. et al. Interplay of LncRNAs NEAT1 and TUG1 in incidence of cytokine storm in appraisal of COVID-19 infection. Int. J. Biol. Sci.18, 4901&#x2013;4913 (2022). 10.7150/ijbs.72318</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.72318</ArticleId><ArticleId IdType="pmc">PMC9379411</ArticleId><ArticleId IdType="pubmed">35982898</ArticleId></ArticleIdList></Reference><Reference><Citation>Gast, M. et al. Long noncoding RNA NEAT1 modulates immune cell functions and is suppressed in early onset myocardial infarction patients. Cardiovasc. Res.115, 1886&#x2013;1906 (2019). 10.1093/cvr/cvz085</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cvr/cvz085</ArticleId><ArticleId IdType="pubmed">30924864</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, L., Xia, J. W., Ke, Z. P. &amp; Zhang, B. H. Blockade of NEAT1 represses inflammation response and lipid uptake via modulating miR-342-3p in human macrophages THP-1 cells. J. Cell. Physiol.234, 5319&#x2013;5326 (2019). 10.1002/jcp.27340</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.27340</ArticleId><ArticleId IdType="pubmed">30259979</ArticleId></ArticleIdList></Reference><Reference><Citation>Devadoss, D. et al. Distinct mucoinflammatory phenotype and the immunomodulatory long noncoding transcripts associated with SARS-CoV-2 airway infection. Preprint at https://www.medrxiv.org/content/10.1101/2021.05.13.21257152v1 (2021).</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.05.13.21257152v1</ArticleId></ArticleIdList></Reference><Reference><Citation>Firoozi, Z. et al. Hsa_circ_0000479/Hsa-miR-149-5p/RIG-I, IL-6 axis: a potential novel pathway to regulate immune response against COVID-19. Can. J. Infect. Dis. Med. Microbiol.2022, 2762582 (2022). 10.1155/2022/2762582</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/2762582</ArticleId><ArticleId IdType="pmc">PMC9448594</ArticleId><ArticleId IdType="pubmed">36081604</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu, S. et al. RNA-Seq revealed a circular RNA-microRNA-mRNA regulatory network in Hantaan virus infection. Front. Cell. Infect. Microbiol.10, 97 (2020). 10.3389/fcimb.2020.00097</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2020.00097</ArticleId><ArticleId IdType="pmc">PMC7083127</ArticleId><ArticleId IdType="pubmed">32232013</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, F., Wu, S., Ren, H. &amp; Gu, J. Klotho suppresses RIG-I-mediated senescence-associated inflammation. Nat. Cell. Biol.13, 254&#x2013;262 (2011). 10.1038/ncb2167</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncb2167</ArticleId><ArticleId IdType="pubmed">21336305</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Multi-omics Blood ATlas (COMBAT) Consortium. A. A blood atlas of COVID-19 defines hallmarks of disease severity and specificity. Cell185, 916&#x2013;938 e958 (2022). 10.1016/j.cell.2022.01.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.012</ArticleId><ArticleId IdType="pmc">PMC8776501</ArticleId><ArticleId IdType="pubmed">35216673</ArticleId></ArticleIdList></Reference><Reference><Citation>Ingraham, N. E. et al. Understanding the renin-angiotensin-aldosterone-SARS-CoV axis: a comprehensive review. Eur. Respir. J.56, 2000912 (2020). 10.1183/13993003.00912-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00912-2020</ArticleId><ArticleId IdType="pmc">PMC7236830</ArticleId><ArticleId IdType="pubmed">32341103</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura, A. et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat. Rev. Immunol.21, 319&#x2013;329 (2021). 10.1038/s41577-021-00536-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00536-9</ArticleId><ArticleId IdType="pmc">PMC8023349</ArticleId><ArticleId IdType="pubmed">33824483</ArticleId></ArticleIdList></Reference><Reference><Citation>Puelles, V. G. et al. Multiorgan and renal tropism of SARS-CoV-2. N. Engl. J. Med.383, 590&#x2013;592 (2020). 10.1056/NEJMc2011400</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2011400</ArticleId><ArticleId IdType="pmc">PMC7240771</ArticleId><ArticleId IdType="pubmed">32402155</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao, F. et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology158, 1831&#x2013;1833.e1833 (2020). 10.1053/j.gastro.2020.02.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2020.02.055</ArticleId><ArticleId IdType="pmc">PMC7130181</ArticleId><ArticleId IdType="pubmed">32142773</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook, H. et al. Long covid-mechanisms, risk factors, and management. BMJ374, n1648 (2021). 10.1136/bmj.n1648</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiang, M. et al. Persistent lung injury and prothrombotic state in long COVID. Front. Immunol.13, 862522 (2022). 10.3389/fimmu.2022.862522</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.862522</ArticleId><ArticleId IdType="pmc">PMC9021447</ArticleId><ArticleId IdType="pubmed">35464473</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe, A. et al. One-year follow-up CT findings in COVID-19 patients: a systematic review and meta-analysis. Respirology27, 605&#x2013;616 (2022). 10.1111/resp.14311</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.14311</ArticleId><ArticleId IdType="pmc">PMC9350074</ArticleId><ArticleId IdType="pubmed">35694728</ArticleId></ArticleIdList></Reference><Reference><Citation>Swenson, K. E. &amp; Swenson, E. R. Pathophysiology of acute respiratory distress syndrome and COVID-19 lung injury. Crit. Care Clin.37, 749&#x2013;776 (2021). 10.1016/j.ccc.2021.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2021.05.003</ArticleId><ArticleId IdType="pmc">PMC8162817</ArticleId><ArticleId IdType="pubmed">34548132</ArticleId></ArticleIdList></Reference><Reference><Citation>Vishnubalaji, R., Shaath, H. &amp; Alajez, N. M. Protein coding and long noncoding RNA (lncRNA) transcriptional landscape in SARS-CoV-2 infected bronchial epithelial cells highlight a role for interferon and inflammatory response. Genes11, 760 (2020). 10.3390/genes11070760</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes11070760</ArticleId><ArticleId IdType="pmc">PMC7397219</ArticleId><ArticleId IdType="pubmed">32646047</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, D. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. J. Am. Med. Assoc.323, 1061&#x2013;1069 (2020).10.1001/jama.2020.1585</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.1585</ArticleId><ArticleId IdType="pmc">PMC7042881</ArticleId><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall, M. The lasting misery of coronavirus long-haulers. Nature585, 339&#x2013;341 (2020). 10.1038/d41586-020-02598-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-020-02598-6</ArticleId><ArticleId IdType="pubmed">32929257</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonow, R. O., Fonarow, G. C., O&#x2019;Gara, P. T. &amp; Yancy, C. W. Association of coronavirus disease 2019 (COVID-19) with myocardial injury and mortality. JAMA Cardiol.5, 751&#x2013;753 (2020). 10.1001/jamacardio.2020.1105</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamacardio.2020.1105</ArticleId><ArticleId IdType="pubmed">32219362</ArticleId></ArticleIdList></Reference><Reference><Citation>Simoneau, C. R. &amp; Ott, M. Modeling multi-organ infection by SARS-CoV-2 using stem cell technology. Cell Stem Cell27, 859&#x2013;868 (2020). 10.1016/j.stem.2020.11.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.11.012</ArticleId><ArticleId IdType="pmc">PMC7713543</ArticleId><ArticleId IdType="pubmed">33275899</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng, Y. Y., Ma, Y. T., Zhang, J. Y. &amp; Xie, X. COVID-19 and the cardiovascular system. Nat. Rev. Cardiol.17, 259&#x2013;260 (2020). 10.1038/s41569-020-0360-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-020-0360-5</ArticleId><ArticleId IdType="pmc">PMC7095524</ArticleId><ArticleId IdType="pubmed">32139904</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms, J. et al. Neurologic features in severe SARS-CoV-2 infection. N. Engl. J. Med.382, 2268&#x2013;2270 (2020). 10.1056/NEJMc2008597</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao, L. et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol.77, 683&#x2013;690 (2020). 10.1001/jamaneurol.2020.1127</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.1127</ArticleId><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Monje, M. &amp; Iwasaki, A. The neurobiology of long COVID. Neuron110, 3484&#x2013;3496 (2022). 10.1016/j.neuron.2022.10.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2022.10.006</ArticleId><ArticleId IdType="pmc">PMC9537254</ArticleId><ArticleId IdType="pubmed">36288726</ArticleId></ArticleIdList></Reference><Reference><Citation>Meydan, C., Madrer, N. &amp; Soreq, H. The neat dance of COVID-19: NEAT1, DANCR, and co-modulated cholinergic RNAs link to inflammation. Front. Immunol.11, 590870 (2020). 10.3389/fimmu.2020.590870</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.590870</ArticleId><ArticleId IdType="pmc">PMC7581732</ArticleId><ArticleId IdType="pubmed">33163005</ArticleId></ArticleIdList></Reference><Reference><Citation>Das, D. &amp; Podder, S. Deregulation of ceRNA networks in frontal cortex and choroid plexus of brain during SARS-CoV-2 infection aggravates neurological manifestations: an insight from bulk and single-cell transcriptomic analyses. Adv. Biol.6, e2101310 (2022).10.1002/adbi.202101310</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adbi.202101310</ArticleId><ArticleId IdType="pmc">PMC9348399</ArticleId><ArticleId IdType="pubmed">35661455</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni, X. et al. Knockdown lncRNA NEAT1 regulates the activation of microglia and reduces AKT signaling and neuronal apoptosis after cerebral ischemic reperfusion. Sci. Rep.10, 19658 (2020). 10.1038/s41598-020-71411-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-71411-1</ArticleId><ArticleId IdType="pmc">PMC7665206</ArticleId><ArticleId IdType="pubmed">33184298</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni, J. et al. MicroRNA let-7c-5p protects against cerebral ischemia injury via mechanisms involving the inhibition of microglia activation. Brain Behav. Immun.49, 75&#x2013;85 (2015). 10.1016/j.bbi.2015.04.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.04.014</ArticleId><ArticleId IdType="pubmed">25934573</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamming, I. et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J. Pathol.203, 631&#x2013;637 (2004). 10.1002/path.1570</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.1570</ArticleId><ArticleId IdType="pmc">PMC7167720</ArticleId><ArticleId IdType="pubmed">15141377</ArticleId></ArticleIdList></Reference><Reference><Citation>Song, E. et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med.218, e20202135 (2020).10.1084/jem.20202135</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu, L. Sleep, exercise, stress, COVID-19, and human health. Heart Mind6, 99&#x2013;100 (2022).10.4103/hm.hm_40_22</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/hm.hm_40_22</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng, S. et al. Facing sleep and mental health problems in the COVID-19 era: what shall we do? Heart Mind6, 203&#x2013;206 (2022).10.4103/hm.hm_38_22</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/hm.hm_38_22</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, Y. et al. The phenotype and prediction of long-term physical, mental and cognitive COVID-19 sequelae 20 months after recovery, a community-based cohort study in China. Mol. Psychiatry28, 1793&#x2013;1801 (2023). 10.1038/s41380-023-01951-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-01951-1</ArticleId><ArticleId IdType="pmc">PMC9869317</ArticleId><ArticleId IdType="pubmed">36690792</ArticleId></ArticleIdList></Reference><Reference><Citation>McWhirter, L. et al. What is brain fog? J. Neurol. Neurosurg. Psychiatry94, 321&#x2013;325 (2022). 10.1136/jnnp-2022-329683</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2022-329683</ArticleId><ArticleId IdType="pubmed">36600580</ArticleId></ArticleIdList></Reference><Reference><Citation>Asadi-Pooya, A. A. et al. Long COVID syndrome-associated brain fog. J. Med. Virol.94, 979&#x2013;984 (2022). 10.1002/jmv.27404</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.27404</ArticleId><ArticleId IdType="pmc">PMC8662118</ArticleId><ArticleId IdType="pubmed">34672377</ArticleId></ArticleIdList></Reference><Reference><Citation>Loretelli, C. et al. PD-1 blockade counteracts post-COVID-19 immune abnormalities and stimulates the anti-SARS-CoV-2 immune response. Jci. Insight6, e146701 (2021). 10.1172/jci.insight.146701</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.146701</ArticleId><ArticleId IdType="pmc">PMC8783674</ArticleId><ArticleId IdType="pubmed">34784300</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyajima, M. et al. Metabolic shift induced by systemic activation of T cells in PD-1-deficient mice perturbs brain monoamines and emotional behavior. Nat. Immunol.18, 1342&#x2013;1352 (2017). 10.1038/ni.3867</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3867</ArticleId><ArticleId IdType="pubmed">29058703</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajakulendran, S. et al. Deletion of chromosome 12q21 affecting KCNC2 and ATXN7L3B in a family with neurodevelopmental delay and ataxia. J. Neurol. Neurosurg. Psychiatry84, 1255&#x2013;1257 (2013). 10.1136/jnnp-2012-304555</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2012-304555</ArticleId><ArticleId IdType="pubmed">23475819</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceban, F. et al. Fatigue and cognitive impairment in Post-COVID-19 Syndrome: a systematic review and meta-analysis. Brain Behav. Immun.101, 93&#x2013;135 (2022). 10.1016/j.bbi.2021.12.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2021.12.020</ArticleId><ArticleId IdType="pmc">PMC8715665</ArticleId><ArticleId IdType="pubmed">34973396</ArticleId></ArticleIdList></Reference><Reference><Citation>Nail, L. M. &amp; Winningham, M. L. Fatigue and weakness in cancer patients: the symptoms experience. Semin. Oncol. Nurs.11, 272&#x2013;278 (1995). 10.1016/S0749-2081(05)80008-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0749-2081(05)80008-7</ArticleId><ArticleId IdType="pubmed">8578035</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrandi, P. J., Alway, S. E. &amp; Mohamed, J. S. The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies. J. Appl. Physiol.129, 864&#x2013;867 (2020). 10.1152/japplphysiol.00321.2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00321.2020</ArticleId><ArticleId IdType="pmc">PMC7832004</ArticleId><ArticleId IdType="pubmed">32673162</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv, Y. et al. Bioinformatics and systems biology approach to identify the pathogenetic link of long COVID and myalgic encephalomyelitis/chronic fatigue syndrome. Front. Immunol.13, 952987 (2022). 10.3389/fimmu.2022.952987</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.952987</ArticleId><ArticleId IdType="pmc">PMC9524193</ArticleId><ArticleId IdType="pubmed">36189286</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribeiro, A. F. Jr. et al. Muscle satellite cells and impaired late stage regeneration in different murine models for muscular dystrophies. Sci. Rep.9, 11842 (2019). 10.1038/s41598-019-48156-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-48156-7</ArticleId><ArticleId IdType="pmc">PMC6694188</ArticleId><ArticleId IdType="pubmed">31413358</ArticleId></ArticleIdList></Reference><Reference><Citation>de Morree, A. et al. Alternative polyadenylation of Pax3 controls muscle stem cell fate and muscle function. Science366, 734&#x2013;738 (2019). 10.1126/science.aax1694</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aax1694</ArticleId><ArticleId IdType="pmc">PMC7046176</ArticleId><ArticleId IdType="pubmed">31699935</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirai, H. et al. MyoD regulates apoptosis of myoblasts through microRNA-mediated down-regulation of Pax3. J. Cell. Biol.191, 347&#x2013;365 (2010). 10.1083/jcb.201006025</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.201006025</ArticleId><ArticleId IdType="pmc">PMC2958479</ArticleId><ArticleId IdType="pubmed">20956382</ArticleId></ArticleIdList></Reference><Reference><Citation>Boutet, S. C. et al. Regulation of Pax3 by proteasomal degradation of monoubiquitinated protein in skeletal muscle progenitors. Cell130, 349&#x2013;362 (2007). 10.1016/j.cell.2007.05.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.05.044</ArticleId><ArticleId IdType="pubmed">17662948</ArticleId></ArticleIdList></Reference><Reference><Citation>Peeling, R. W., Heymann, D. L., Teo, Y. Y. &amp; Garcia, P. J. Diagnostics for COVID-19: moving from pandemic response to control. Lancet399, 757&#x2013;768 (2022). 10.1016/S0140-6736(21)02346-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02346-1</ArticleId><ArticleId IdType="pmc">PMC8687671</ArticleId><ArticleId IdType="pubmed">34942102</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical management of COVID-19: living guideline, 13 January 2023. (World Health Organization, Geneva, 2023) (WHO/2019-nCoV/clinical/2023.1).</Citation></Reference><Reference><Citation>Chen, B. et al. Targeting non-coding RNAs to overcome cancer therapy resistance. Signal Transduct. Target. Ther.7, 121 (2022). 10.1038/s41392-022-00975-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-022-00975-3</ArticleId><ArticleId IdType="pmc">PMC9008121</ArticleId><ArticleId IdType="pubmed">35418578</ArticleId></ArticleIdList></Reference><Reference><Citation>Haroun, R. A. et al. Circulating plasma miR-155 is a potential biomarker for the detection of SARS-CoV-2 infection. Pathology54, 104&#x2013;110 (2022). 10.1016/j.pathol.2021.09.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pathol.2021.09.006</ArticleId><ArticleId IdType="pmc">PMC8570980</ArticleId><ArticleId IdType="pubmed">34838331</ArticleId></ArticleIdList></Reference><Reference><Citation>Taheri, M. et al. Evaluation of expression of VDR-associated lncRNAs in COVID-19 patients. BMC Infect. Dis.21, 588 (2021). 10.1186/s12879-021-06248-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-021-06248-8</ArticleId><ArticleId IdType="pmc">PMC8214050</ArticleId><ArticleId IdType="pubmed">34147082</ArticleId></ArticleIdList></Reference><Reference><Citation>The Novel Coronavirus Pneumonia Emergency Response Epidemiology, T. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) - China, 2020. China CDC Wkly2, 113&#x2013;122 (2020). 10.46234/ccdcw2020.032</Citation><ArticleIdList><ArticleId IdType="doi">10.46234/ccdcw2020.032</ArticleId><ArticleId IdType="pmc">PMC8392929</ArticleId><ArticleId IdType="pubmed">34594836</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, H. et al. Otud7b facilitates T cell activation and inflammatory responses by regulating Zap70 ubiquitination. J. Exp. Med.213, 399&#x2013;414 (2016). 10.1084/jem.20151426</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20151426</ArticleId><ArticleId IdType="pmc">PMC4813674</ArticleId><ArticleId IdType="pubmed">26903241</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo, Q. et al. MicroRNA-486-5p promotes acute lung injury via inducing inflammation and apoptosis by targeting OTUD7B. Inflammation43, 975&#x2013;984 (2020). 10.1007/s10753-020-01183-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10753-020-01183-3</ArticleId><ArticleId IdType="pubmed">31940107</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Giralt, N. et al. Circulating microRNA profiling is altered in the acute respiratory distress syndrome related to SARS-CoV-2 infection. Sci. Rep.12, 6929 (2022). 10.1038/s41598-022-10738-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-022-10738-3</ArticleId><ArticleId IdType="pmc">PMC9047579</ArticleId><ArticleId IdType="pubmed">35484171</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, H. B. et al. Role of signaling pathway of long non-coding RNA growth arrest-specific transcript 5/microRNA-200c-3p/angiotensin converting enzyme 2 in the apoptosis of human lung epithelial cell A549 in acute respiratory distress syndrome. Zhonghua Yi Xue Za Zhi98, 3354&#x2013;3359 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30440128</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayeldeen, G. et al. The impact of lncRNA-GAS5/miRNA-200/ACE2 molecular pathway on the severity of COVID-19. Curr. Med. Chem.10.2174/0929867330666230515144133 (2023).</Citation></Reference><Reference><Citation>Collaborators, C.-E. M. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21. Lancet399, 1513&#x2013;1536 (2022). 10.1016/S0140-6736(21)02796-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02796-3</ArticleId><ArticleId IdType="pmc">PMC8912932</ArticleId><ArticleId IdType="pubmed">35279232</ArticleId></ArticleIdList></Reference><Reference><Citation>Nahand, J. S. et al. The role of miR-146a in viral infection. IUBMB Life72, 343&#x2013;360 (2020). 10.1002/iub.2222</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.2222</ArticleId><ArticleId IdType="pubmed">31889417</ArticleId></ArticleIdList></Reference><Reference><Citation>Frieman, M. et al. Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J. Virol.81, 9812&#x2013;9824 (2007). 10.1128/JVI.01012-07</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01012-07</ArticleId><ArticleId IdType="pmc">PMC2045396</ArticleId><ArticleId IdType="pubmed">17596301</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, Y. &amp; Li, L. Depleting microRNA-146a-3p attenuates lipopolysaccharide-induced acute lung injury via up-regulating SIRT1 and mediating NF-kappaB pathway. J. Drug Target.29, 420&#x2013;429 (2021). 10.1080/1061186X.2020.1850738</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1061186X.2020.1850738</ArticleId><ArticleId IdType="pubmed">33185125</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafarinejad-Farsangi, S., Jazi, M. M., Rostamzadeh, F. &amp; Hadizadeh, M. High affinity of host human microRNAs to SARS-CoV-2 genome: an in silico analysis. Noncoding RNA Res.5, 222&#x2013;231 (2020). 10.1016/j.ncrna.2020.11.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncrna.2020.11.005</ArticleId><ArticleId IdType="pmc">PMC7680021</ArticleId><ArticleId IdType="pubmed">33251388</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui, Y. et al. Mir-29a-3p improves acute lung injury by reducing alveolar epithelial cell panoptosis. Aging Dis.13, 899&#x2013;909 (2022). 10.14336/AD.2021.1023</Citation><ArticleIdList><ArticleId IdType="doi">10.14336/AD.2021.1023</ArticleId><ArticleId IdType="pmc">PMC9116916</ArticleId><ArticleId IdType="pubmed">35656115</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Z. H. et al. The long noncoding RNA THRIL regulates TNF alpha expression through its interaction with hnRNPL. Proc. Natl. Acad. Sci. USA111, 1002&#x2013;1007 (2014). 10.1073/pnas.1313768111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1313768111</ArticleId><ArticleId IdType="pmc">PMC3903238</ArticleId><ArticleId IdType="pubmed">24371310</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou, H. J. et al. Long noncoding RNA MALAT1 contributes to inflammatory response of microglia following spinal cord injury via the modulation of a miR-199b/IKKbeta/NF-kappaB signaling pathway. Am. J. Physiol. Cell Physiol.315, C52&#x2013;C61 (2018). 10.1152/ajpcell.00278.2017</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.00278.2017</ArticleId><ArticleId IdType="pubmed">29631367</ArticleId></ArticleIdList></Reference><Reference><Citation>Keikha, R., Hashemi-Shahri, S. M. &amp; Jebali, A. The relative expression of miR-31, miR-29, miR-126, and miR-17 and their mRNA targets in the serum of COVID-19 patients with different grades during hospitalization. Eur. J. Med. Res.26, 75 (2021). 10.1186/s40001-021-00544-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40001-021-00544-4</ArticleId><ArticleId IdType="pmc">PMC8276226</ArticleId><ArticleId IdType="pubmed">34256840</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbatinelli, J. et al. Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients. Mech. Ageing Dev.193, 111413 (2021). 10.1016/j.mad.2020.111413</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2020.111413</ArticleId><ArticleId IdType="pmc">PMC7722494</ArticleId><ArticleId IdType="pubmed">33307107</ArticleId></ArticleIdList></Reference><Reference><Citation>Onder, G., Rezza, G. &amp; Brusaferro, S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. J. Am. Med. Assoc.323, 1775&#x2013;1776 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32203977</ArticleId></ArticleIdList></Reference><Reference><Citation>Peckham, H. et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat. Commun.11, 6317 (2020). 10.1038/s41467-020-19741-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19741-6</ArticleId><ArticleId IdType="pmc">PMC7726563</ArticleId><ArticleId IdType="pubmed">33298944</ArticleId></ArticleIdList></Reference><Reference><Citation>Vai, B. et al. Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis. Lancet Psychiatry8, 797&#x2013;812 (2021). 10.1016/S2215-0366(21)00232-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00232-7</ArticleId><ArticleId IdType="pmc">PMC8285121</ArticleId><ArticleId IdType="pubmed">34274033</ArticleId></ArticleIdList></Reference><Reference><Citation>Pimenta, R. et al. MiR-200c-3p expression may be associated with worsening of the clinical course of patients with COVID-19. Mol. Biol. Res. Commun.10, 141&#x2013;147 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8340313</ArticleId><ArticleId IdType="pubmed">34476267</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, J. et al. Association of sex with clinical outcomes in COVID-19 patients: a retrospective analysis of 1190 cases. Respir. Med.173, 106159 (2020). 10.1016/j.rmed.2020.106159</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rmed.2020.106159</ArticleId><ArticleId IdType="pmc">PMC7521447</ArticleId><ArticleId IdType="pubmed">33010731</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu, Y. et al. A potentially functional polymorphism in the promoter region of miR-34b/c is associated with an increased risk for primary hepatocellular carcinoma. Int. J. Cancer128, 412&#x2013;417 (2011). 10.1002/ijc.25342</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ijc.25342</ArticleId><ArticleId IdType="pubmed">20309940</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebert, L. F. et al. Miravirsen (SPC3649) can inhibit the biogenesis of miR-122. Nucleic Acids Res.42, 609&#x2013;621 (2014). 10.1093/nar/gkt852</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkt852</ArticleId><ArticleId IdType="pmc">PMC3874169</ArticleId><ArticleId IdType="pubmed">24068553</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu, D. &amp; Thum, T. RNA-based diagnostic and therapeutic strategies for cardiovascular disease. Nat. Rev. Cardiol.16, 661&#x2013;674 (2019). 10.1038/s41569-019-0218-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41569-019-0218-x</ArticleId><ArticleId IdType="pubmed">31186539</ArticleId></ArticleIdList></Reference><Reference><Citation>Dube, U. et al. An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations. Nat. Neurosci.22, 1903&#x2013;1912 (2019). 10.1038/s41593-019-0501-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0501-5</ArticleId><ArticleId IdType="pmc">PMC6858549</ArticleId><ArticleId IdType="pubmed">31591557</ArticleId></ArticleIdList></Reference><Reference><Citation>Akula, S. M., Bolin, P. &amp; Cook, P. P. Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating nsp10 gene. RNA Biol.19, 1&#x2013;11 (2022). 10.1080/15476286.2021.2010959</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15476286.2021.2010959</ArticleId><ArticleId IdType="pmc">PMC8786335</ArticleId><ArticleId IdType="pubmed">34904915</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta, A. et al. Early treatment for Covid-19 with SARS-CoV-2 neutralizing antibody sotrovimab. New Engl. J. Med.385, 1941&#x2013;1950 (2021). 10.1056/NEJMoa2107934</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2107934</ArticleId><ArticleId IdType="pubmed">34706189</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinreich, D. M. et al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. New Engl. J. Med.384, 238&#x2013;251 (2021). 10.1056/NEJMoa2035002</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2035002</ArticleId><ArticleId IdType="pmc">PMC7781102</ArticleId><ArticleId IdType="pubmed">33332778</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, Y. et al. Evaluation of adverse events of bamlanivimab, bamlanivimab/etesevimab used for COVID-19 based on FAERS database. Expert Opin. Drug Saf.22, 1&#x2013;8 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36178050</ArticleId></ArticleIdList></Reference><Reference><Citation>Nhean, S. et al. COVID-19: a review of potential treatments (corticosteroids, remdesivir, tocilizumab, bamlanivimab/etesevimab, and casirivimab/imdevimab) and pharmacological considerations. J. Pharm. Pract. 36, 407&#x2013;417 (2023).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10064180</ArticleId><ArticleId IdType="pubmed">34597525</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, X. et al. COVID-19: progress in diagnostics, therapy and vaccination. Theranostics10, 7821&#x2013;7835 (2020). 10.7150/thno.47987</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.47987</ArticleId><ArticleId IdType="pmc">PMC7359073</ArticleId><ArticleId IdType="pubmed">32685022</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu, L. et al. Circular RNA vaccines against SARS-CoV-2 and emerging variants. Cell185, 1728&#x2013;1744.e1716 (2022). 10.1016/j.cell.2022.03.044</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.03.044</ArticleId><ArticleId IdType="pmc">PMC8971115</ArticleId><ArticleId IdType="pubmed">35460644</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah, A. M. &amp; Giacca, M. Small non-coding RNA therapeutics for cardiovascular disease. Eur. Heart J.43, 4548&#x2013;4561 (2022). 10.1093/eurheartj/ehac463</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac463</ArticleId><ArticleId IdType="pmc">PMC9659475</ArticleId><ArticleId IdType="pubmed">36106499</ArticleId></ArticleIdList></Reference><Reference><Citation>Palihaderu, P. et al. Therapeutic potential of miRNAs for type 2 diabetes mellitus: an overview. Epigenet. Insights15, 25168657221130041 (2022). 10.1177/25168657221130041</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/25168657221130041</ArticleId><ArticleId IdType="pmc">PMC9575458</ArticleId><ArticleId IdType="pubmed">36262691</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Q. et al. Regulatory roles of microRNAs in insect pests: prospective targets for insect pest control. Curr. Opin. Biotechnol.70, 158&#x2013;166 (2021). 10.1016/j.copbio.2021.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.copbio.2021.05.002</ArticleId><ArticleId IdType="pubmed">34090114</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouchie, A. First microRNA mimic enters clinic. Nat. Biotechnol.31, 577&#x2013;577 (2013). 10.1038/nbt0713-577</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt0713-577</ArticleId><ArticleId IdType="pubmed">23839128</ArticleId></ArticleIdList></Reference><Reference><Citation>Trujillo, R. D. et al. The potential functions of primary microRNAs in target recognition and repression. EMBO J.29, 3272&#x2013;3285 (2010). 10.1038/emboj.2010.208</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2010.208</ArticleId><ArticleId IdType="pmc">PMC2957211</ArticleId><ArticleId IdType="pubmed">20808284</ArticleId></ArticleIdList></Reference><Reference><Citation>Dugas, J. C. et al. Dicer1 and miR-219 are required for normal oligodendrocyte differentiation and myelination. Neuron65, 597&#x2013;611 (2010). 10.1016/j.neuron.2010.01.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.01.027</ArticleId><ArticleId IdType="pmc">PMC2843397</ArticleId><ArticleId IdType="pubmed">20223197</ArticleId></ArticleIdList></Reference><Reference><Citation>Moyano, A. L. et al. MicroRNA-219 reduces viral load and pathologic changes in theiler&#x2019;s virus-induced demyelinating disease. Mol. Ther.26, 730&#x2013;743 (2018). 10.1016/j.ymthe.2018.01.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ymthe.2018.01.008</ArticleId><ArticleId IdType="pmc">PMC5910888</ArticleId><ArticleId IdType="pubmed">29433936</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolter, J. M. et al. Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA. Nature587, 281&#x2013;284 (2020). 10.1038/s41586-020-2835-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2835-2</ArticleId><ArticleId IdType="pmc">PMC8020672</ArticleId><ArticleId IdType="pubmed">33087932</ArticleId></ArticleIdList></Reference><Reference><Citation>Phelan, J. D. &amp; Staudt, L. M. CRISPR-based technology to silence the expression of IncRNAs. Proc. Natl. Acad. Sci. USA117, 8225&#x2013;8227 (2020). 10.1073/pnas.2003702117</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2003702117</ArticleId><ArticleId IdType="pmc">PMC7165436</ArticleId><ArticleId IdType="pubmed">32245807</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng, Y. et al. Improved nucleic acid therapy with advanced nanoscale biotechnology. Mol. Ther. Nucleic Acids19, 581&#x2013;601 (2020). 10.1016/j.omtn.2019.12.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2019.12.004</ArticleId><ArticleId IdType="pmc">PMC6957827</ArticleId><ArticleId IdType="pubmed">31927331</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning, L. et al. Development and application of ribonucleic acid therapy strategies against COVID-19. Int. J. Biol. Sci.18, 5070&#x2013;5085 (2022). 10.7150/ijbs.72706</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.72706</ArticleId><ArticleId IdType="pmc">PMC9379410</ArticleId><ArticleId IdType="pubmed">35982905</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfafenrot, C. et al. Inhibition of SARS-CoV-2 coronavirus proliferation by designer antisense-circRNAs. Nucleic Acids Res.49, 12502&#x2013;12516 (2021). 10.1093/nar/gkab1096</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkab1096</ArticleId><ArticleId IdType="pmc">PMC8643703</ArticleId><ArticleId IdType="pubmed">34850109</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, C. X. &amp; Chen, L. L. Circular RNAs: characterization, cellular roles, and applications. Cell185, 2390 (2022). 10.1016/j.cell.2022.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.001</ArticleId><ArticleId IdType="pubmed">35584701</ArticleId></ArticleIdList></Reference><Reference><Citation>Trobaugh, D. W. &amp; Klimstra, W. B. MicroRNA regulation of RNA virus replication and pathogenesis. Trends Mol. Med.23, 80&#x2013;93 (2017). 10.1016/j.molmed.2016.11.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2016.11.003</ArticleId><ArticleId IdType="pmc">PMC5836316</ArticleId><ArticleId IdType="pubmed">27989642</ArticleId></ArticleIdList></Reference><Reference><Citation>Vierbuchen, T. &amp; Fitzgerald, K. A. Long non-coding RNAs in antiviral immunity. Semin. Cell. Dev. Biol.111, 126&#x2013;134 (2021). 10.1016/j.semcdb.2020.06.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semcdb.2020.06.009</ArticleId><ArticleId IdType="pubmed">32580911</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao, X. J. et al. Circular RNAs as emerging regulators in COVID-19 pathogenesis and progression. Front. Immunol.13, 980231 (2022). 10.3389/fimmu.2022.980231</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.980231</ArticleId><ArticleId IdType="pmc">PMC9681929</ArticleId><ArticleId IdType="pubmed">36439162</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar, A. et al. COVID-19 mechanisms in the human body-what we know so far. Front. Immunol.12, 693938 (2021). 10.3389/fimmu.2021.693938</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.693938</ArticleId><ArticleId IdType="pmc">PMC8592035</ArticleId><ArticleId IdType="pubmed">34790191</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen, Q. et al. The ACE2 expression in Sertoli cells and germ cells may cause male reproductive disorder after SARS-CoV-2 infection. J. Cell. Mol. Med.24, 9472&#x2013;9477 (2020). 10.1111/jcmm.15541</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.15541</ArticleId><ArticleId IdType="pmc">PMC7361928</ArticleId><ArticleId IdType="pubmed">32594644</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni, C. et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet399, 1618&#x2013;1624 (2022). 10.1016/S0140-6736(22)00327-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00327-0</ArticleId><ArticleId IdType="pmc">PMC8989396</ArticleId><ArticleId IdType="pubmed">35397851</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, L. et al. Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: a systematic review, meta-analysis and call for action. EClinicalMedicine40, 101111 (2021). 10.1016/j.eclinm.2021.101111</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101111</ArticleId><ArticleId IdType="pmc">PMC8424080</ArticleId><ArticleId IdType="pubmed">34514362</ArticleId></ArticleIdList></Reference><Reference><Citation>Su, S. et al. Epidemiology, clinical presentation, pathophysiology, and management of long COVID: an update. Mol. Psychiatry10.1038/s41380-023-02171-3 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37491461</ArticleId></ArticleIdList></Reference><Reference><Citation>Han, Y. et al. Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions. Transl. Psychiatry11, 499 (2021). 10.1038/s41398-021-01629-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-021-01629-8</ArticleId><ArticleId IdType="pmc">PMC8482959</ArticleId><ArticleId IdType="pubmed">34593760</ArticleId></ArticleIdList></Reference><Reference><Citation>Schultze, J. L. &amp; Aschenbrenner, A. C. COVID-19 and the human innate immune system. Cell184, 1671&#x2013;1692 (2021). 10.1016/j.cell.2021.02.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.02.029</ArticleId><ArticleId IdType="pmc">PMC7885626</ArticleId><ArticleId IdType="pubmed">33743212</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdolahi, S. et al. Evaluation of miR-200c-3p and miR-421-5p levels during immune responses in the admitted and recovered COVID-19 subjects. Infect. Genet. Evol.98, 105207 (2022). 10.1016/j.meegid.2022.105207</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2022.105207</ArticleId><ArticleId IdType="pmc">PMC8730736</ArticleId><ArticleId IdType="pubmed">34999004</ArticleId></ArticleIdList></Reference><Reference><Citation>Demiray, A. et al. Serum microRNA signature is capable of predictive and prognostic factor for SARS-COV-2 virulence. Turk. J. Biochem.46, 245&#x2013;253 (2021).10.1515/tjb-2020-0520</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/tjb-2020-0520</ArticleId></ArticleIdList></Reference><Reference><Citation>Fayyad-Kazan, M. et al. Circulating miRNAs: potential diagnostic role for coronavirus disease 2019 (COVID-19). Infect. Genet. Evol.94, 105020 (2021). 10.1016/j.meegid.2021.105020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2021.105020</ArticleId><ArticleId IdType="pmc">PMC8325559</ArticleId><ArticleId IdType="pubmed">34343725</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambardella, J. et al. Role of endothelial miR-24 in COVID-19 cerebrovascular events. Crit. Care25, 306 (2021). 10.1186/s13054-021-03731-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-021-03731-1</ArticleId><ArticleId IdType="pmc">PMC8385482</ArticleId><ArticleId IdType="pubmed">34433473</ArticleId></ArticleIdList></Reference><Reference><Citation>Grehl, C. et al. Detection of SARS-CoV-2 derived small RNAs and changes in circulating small RNAs associated with COVID-19. Viruses13, 1593 (2021). 10.3390/v13081593</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v13081593</ArticleId><ArticleId IdType="pmc">PMC8402885</ArticleId><ArticleId IdType="pubmed">34452458</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, C., Hu, X., Li, L. &amp; Li, J. H. Differential microRNA expression in the peripheral blood from human patients with COVID-19. J. Clin. Lab. Anal.34, e23590 (2020). 10.1002/jcla.23590</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.23590</ArticleId><ArticleId IdType="pmc">PMC7536972</ArticleId><ArticleId IdType="pubmed">32960473</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Fleta, P. et al. A differential signature of circulating miRNAs and cytokines between COVID-19 and community-acquired pneumonia uncovers novel physiopathological mechanisms of COVID-19. Front. Immunol.12, 815651 (2021). 10.3389/fimmu.2021.815651</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.815651</ArticleId><ArticleId IdType="pmc">PMC8787267</ArticleId><ArticleId IdType="pubmed">35087533</ArticleId></ArticleIdList></Reference><Reference><Citation>Meidert, A. S. et al. Extracellular vesicle associated miRNAs regulate signaling pathways involved in covid-19 pneumonia and the progression to severe acute respiratory corona virus-2 syndrome. Front. Immunol.12, 784028 (2021). 10.3389/fimmu.2021.784028</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.784028</ArticleId><ArticleId IdType="pmc">PMC8696174</ArticleId><ArticleId IdType="pubmed">34956213</ArticleId></ArticleIdList></Reference><Reference><Citation>Srivastava, S. et al. Evaluation of altered miRNA expression pattern to predict COVID-19 severity. Heliyon9, e13388 (2023). 10.1016/j.heliyon.2023.e13388</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2023.e13388</ArticleId><ArticleId IdType="pmc">PMC9889280</ArticleId><ArticleId IdType="pubmed">36743852</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang, Y. et al. Plasma cell-free RNA characteristics in COVID-19 patients. Genome Res.32, 228&#x2013;241 (2022). 10.1101/gr.276175.121</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/gr.276175.121</ArticleId><ArticleId IdType="pmc">PMC8805721</ArticleId><ArticleId IdType="pubmed">35064006</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, P. et al. Downregulated miR-451a as a feature of the plasma cfRNA landscape reveals regulatory networks of IL-6/IL-6R-associated cytokine storms in COVID-19 patients. Cell. Mol. Immunol.18, 1064&#x2013;1066 (2021). 10.1038/s41423-021-00652-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-021-00652-5</ArticleId><ArticleId IdType="pmc">PMC7907785</ArticleId><ArticleId IdType="pubmed">33637960</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, Y. et al. Comparative analysis of long non-coding RNA expression and immune response in mild and severe COVID-19. Front. Mol. Biosci.9, 835590 (2022). 10.3389/fmolb.2022.835590</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2022.835590</ArticleId><ArticleId IdType="pmc">PMC9094366</ArticleId><ArticleId IdType="pubmed">35573725</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>